Retinal Physician – Artificial Intelligence as a Disruptor to AMD Diagnosis
Companies plan for an expanded role for AI in retina therapies.
Related Articles
The Evolution of Clinical Trial Endpoints for Diabetic Retinopathy
Considerable advancements, occurring over the past several decades, contributed to the refinement and evolution of DR clinical endpoints.
The Pathology of Stargardt Disease and Future Treatment Horizons
Understanding the clinical presentation and underlying pathology of Stargardt disease is crucial for identifying patients as well as developing and offering effective treatments. Ongoing research…
FDA Grants Key Designation for RP Therapy
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.
Overview of Retinal Prosthesis and Future Directions
With technological advancements in retinal prostheses, patients with severe visual impairment or blindness may have the potential to regain both partial sight and a sense…
ViGeneron Receives FDA Clearance
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.
Tyrosine Kinase Inhibitors for Wet AMD and Diabetic Retinopathy
Tyrosine kinase inhibitors act at a different location than anti-VEGFs. They inhibit the intracellular domain of VEGFR, whereas anti-VEGF molecules bind to and prevent VEGF…
Eylea HD Extended Dosing for RVO
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.
Welcome Diana Do
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.
Considerations in Management of Dry AMD
The new landscape of treatment for AMD provides more options for vision preservation but leaves many questions unanswered, especially when it comes to treating both…
Ultra-Widefield Image of the Month
A 71-year-old female presented with progressively worsening vision in her left eye. Exam and imaging with Optos optomap UWF demonstrated a medium-sized, peripapillary choroidal melanoma…